Cargando…

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients

Characterization, diagnosis, and treatment of colorectal cancers (CRC) is difficult due to limited biopsy information, impracticality of repeated biopsies, and cancer biomarker fallibility. Circulating tumor DNA (ctDNA) has recently been investigated as a non-invasive way to gain representative gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ying-Chi, Wang, Dong, Jin, Lan, Yao, Hong-Wei, Zhang, Jing-Hui, Wang, Jin, Zhao, Xiao-Mu, Shen, Chun-Ying, Chen, Wei, Wang, Xue-Liang, Shi, Rong, Chen, Si-Yi, Zhang, Zhong-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066652/ https://www.ncbi.nlm.nih.gov/pubmed/29914973 http://dx.doi.org/10.1042/BSR20180322

Ejemplares similares

Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection
por: Yu, Jun-Hui, et al.
Publicado: (2020)

Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing
por: Chen, Ke-Zhong, et al.
Publicado: (2016)

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
por: Hu, Ying, et al.
Publicado: (2020)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
por: Peng, Hao, et al.
Publicado: (2019)

Prognostic Value of Lymphovascular Invasion in Patients with Stage III Colorectal Cancer: A Retrospective Study
por: Zhong, Jin-Wei, et al.
Publicado: (2019)

Building personalized treatment plans for early-stage colorectal cancer patients
por: Lin, Hung-Hsin, et al.
Publicado: (2017)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients
por: Sun, Fan, et al.
Publicado: (2018)

Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
por: Zhu, Ning, et al.
Publicado: (2022)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Role of circulating tumor DNA in the management of early‐stage lung cancer
por: Zhao, Heng, et al.
Publicado: (2018)

Prevalence of Toxoplasma gondii antibodies, circulating antigens and DNA in stray cats in Shanghai, China
por: Wang, Quan, et al.
Publicado: (2012)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer
por: Huang, Chien-Hung, et al.
Publicado: (2014)

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
por: Gao, Zhaoya, et al.
Publicado: (2023)

Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage
por: Wang, Kun, et al.
Publicado: (2021)

Exploring the Association of Innate Immunity Biomarkers With MRI Features in Both Early and Late Stages Osteoarthritis
por: Rajandran, Sureka Naidu, et al.
Publicado: (2020)

Lacunes are associated with late-stage multiple sclerosis comorbidities
por: Zhang, Lijie, et al.
Publicado: (2023)

Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer
por: An, Ning, et al.
Publicado: (2015)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019)

Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells
por: Feng, Chengbao, et al.
Publicado: (2020)

Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2023)

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
por: Wang, Zhe-Ying, et al.
Publicado: (2019)

Predicting late-stage age-related macular degeneration by integrating marginally weak SNPs in GWA studies
por: Zhou, Xueping, et al.
Publicado: (2023)

Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts
por: Wu, Qingbin, et al.
Publicado: (2023)

Effects of clean intermittent self-catheterization on late bladder dysfunction after radical hysterectomy in cervical cancer
por: Shen, Xia, et al.
Publicado: (2019)

Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction
por: Li, Ying-Qing, et al.
Publicado: (2013)

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy
por: Chang, Yu-Tang, et al.
Publicado: (2023)

Late-stage functionalization of 5-nitrofurans derivatives and their antibacterial activities
por: Chen, Geshuyi, et al.
Publicado: (2023)

Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis
por: Fang, Zengli, et al.
Publicado: (2020)

Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo
por: Shen, Wei, et al.
Publicado: (2009)

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
por: Yang, Meng, et al.
Publicado: (2017)

Head-nodding: a driving force for the circulation of cerebrospinal fluid
por: Xu, Qiang, et al.
Publicado: (2021)

Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer
por: Wang, Rui, et al.
Publicado: (2011)

Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro
por: Hou, Yong-Qiang, et al.
Publicado: (2020)

Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish
por: Korzh, Svetlana, et al.
Publicado: (2008)

High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype
por: Huang, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ecot3o1m7mg8t63gcdfmvjsnl7